Astrazeneca AB v. Aurobindo Pharma Ltd. > Documents

Date Field	Doc. No.	Description (Pages)
Jul 17, 2017	3	ORDER filed. Actavis's motion [445033-2] is granted. Appeal No. 2017-1778 is dismissed. Appeal No. 2017-1779 is dismissed for failure to prosecute. Each side shall bear its own costs in Appeal No. 2017-1778 and Appeal No. 2017-1779. The revised official caption and short caption for Appeal No. 2017-1777 is reflected in this order. Mylan's opening brief submitted on July 7, 2017 is accepted for filing. AstraZeneca AB's response brief is due no later than 40 days from the date of filing of this order. ISSUED AS A MANDATE (as to 2017-1778 only): July 17, 2017. Service: 07/17/2017 by clerk. [446905] [17-1777, 17-1778, 17-1779] [LMS] [Entered: 07/17/2017 11:06 AM] (4)
Mar 9, 2017	1	Appeal docketed. Received: 03/06/2017. [414145] [MJL] [Entered: 03/09/2017 05:15 PM] (51)
Mar 9, 2017	2	Note to file: The following cases are consolidated: 17-1777 (Lead) with 17-1778 and 17-1779 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [414157] [17-1777, 17-1778, 17-1779] [MJL] [Entered: 03/09/2017 05:24 PM] (0)